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There are many factors that contribute to human cancer. One of the first well-known 
analyses	published	by	Dool	and	Peto	(1)	showed	that	the	major	factors	were	nutrition	
(35%)	and	tobacco	use	(30%).	The	next	mentioned	were	infection	agents	(10%),	sexual	
behaviour	(7%),	industrial	occupation	(4%),	alcohol	consumption	(3%),	environmental	
pollution	(2%)	and	others.	Unfortunately,	there	are	no	clear	estimates	for	the	causes	of	
colorectal	 cancer.	Lichtenstein	estimated	 that	60%	of	observed	colorectal	 cancers	are	
due	to	risky	life-style,	35%	due	to	genetic	predisposition,	and	only	5%	because	of	harm-
ful	environmental	factors	(2).
Dietary factors
There	is	general	agreement	that	the	main	role	in	the	development	of	colorectal	cancer	
plays	dietary	habits.	“Diet”	covers	different	types	of	food,	macro-	and	micronutrients.	
Despite	many	studies	performed	up	to	date,	the	knowledge	on	the	role	of	dietary	factors	
in	the	etiology	of	colorectal	cancer	is	inconsistent.
Dietary fibre
Dietary fibre is one of the most frequently cited macronutrients that may play protective 
role in colorectal cancer. It was first hypothesized in the 1960, that “the pattern of (non-
infectious)	colon	disease	in	the	Africans	...	(was	largely	due	to	the	role	of)	natural	Afri-
can diet usually high in their fibre content ... (3)”. Dietary fibre was defined by Trowel in 
1976	as	“the	residue	of	plant	food	resistant	to	hydrolysis	by	human	alimentary	enzymes”	
(4), while “dietary fibre complex” referred to all substances of dietary fibre plus all 
chemical	compounds	naturally	associated	with,	and	concentrated	around	these	structural	
polymers. Dietary fibre covers a lot of substances, like cellulose, hemicelluloses, lignin, 
pectin, gums and mucilages (5). To avoid misclassification of dietary fibre the Associa-
tion of Official Analytical Chemists and the US Food and Drug Administration updated 
the definition. Thus, dietary fibre covers all dietary polysaccharides of 10 and more de-
grees	of	polymerisation	(6).
There are some possible explanations of the protective effect of dietary fibre on the 
colon	and	rectum.	Fibre	in	natural	way	holds	water,	and	thus	dilutes	carcinogens	com-
prised in food. Water holding by dietary fibre increases faecal volume and in this way 
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shortens	 intestinal	 transit	 time.	 This	 reduces	 the	 time	 carcinogens	 remain	 in	 contact	
with	colon	wall,	and	decreases	their	carcinogenic	effect	(7,	8).	Moreover,	Fleming	et	al.	
showed that dietary fibre caused large faecal output, frequent defecations and favourably 
influenced colonic function (9, 10). There is also evidence, published by McCullough 
for fibre associated hypertrophy in the colon. McCullough also observed that an increase 
in	the	number	of	crypts	per	circumference	and	the	number	of	branched	crypts	was	the	
effect of dietary fibre (11).
Fibre	is	relatively	resistant	to	fermentation,	however,	some	components	are	fermented	
by gut microflora to produce three main short-chain fatty acids: butyric acid, acetic acid 
and	propionic	acid.	These	have	also	antycarcinogenic	effect	by	reducing	the	pH	in	the	
content	of	the	large	intestine,	they	alter	microbial	metabolism	and	lower	ammonia	levels	
(12).	Champ	recognised	butyrate	acid	as	the	main	nutrient	of	the	colonocyte	(13)	and	
Pool-Zobel	showed	that	it	may	reduce	colon	cancer	risk	by	suppressing	the	proliferation	
of tumour cells and induction of detoxification enzyme glutatione S-transferase (14).
Although, there is growing evidence on protective effect of dietary fibre in animal 
and	human	models,	the	results	from	epidemiologic	studies	are	inconsistent.
Howe	et	al.	in	1992	presented	the	results	from	thirteen	case-control	studies	showing	
47%	reduction	in	colorectal	cancer	risk	among	those,	who	consumed	at	least	26.2	grams	
of fibre daily (15). Thun in Cancer Prevention Study-II observed protective effect of 
fibre only among women (RR = 0.62; 95% CI: 0.45–0.86), in men the relationship was 
not statistically significant (16). Protective effect of fibre was also observed in Health 
Professionals	Follow-up	Study	(17).	However,	the	results	from	the	Nurses’	Health	Study	
(18),	the	Iowa	Women’s	Health	Study	(19),	the	Alpha-Tocopherol,	Beta-Carotene	Can-
cer	Prevention	Study	(20),	the	Swedish	Mammography	Screening	Cohort	(21)	and	the	
Figure 4.1. The role of dietary fibre in the etiology of colorectal cancer
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Breast Cancer Detection Demonstration Project (22) did not confirm statistically signifi-
cant protective role of fibre in colorectal cancer. Moreover, Boniton-Kopp in the Euro-
pean	Cancer	Prevention	Intervention	Study	has	found,	that	supplementation	of	3.5	g/day	
of fibre from ispaghula husk increased the risk of developing colon polyps (23).
Fruits and vegetables
Epidemiologic	studies	showed	that	diet,	rich	in	fruits	and	vegetables,	has	been	associated	
with	reduced	risk	of	colorectal	cancer.	Fruits	and	vegetables	are	natural	source	of	poten-
tially anticarcinogenic substances, like fibre, flavonoids, folic acid, carotenoids, vitamin 
C	and	E,	 selenium,	 allium	compounds,	 coumarins,	 dithiolothiones,	 indole-3-carbinol,	
isoflavones, isothiocyanates, phytosterols, saponins and protease inhibitors. Some sub-
stances are specific for one type or group of fruits or vegetables others are not.
Cruciferous vegetables, such as cauliflower, broccoli, cabbage and brussels sprouts 
are	 rich	 in	 dithiolthiones	 and	 isothiocyanates	 –	 substances	 that	 have	 been	 showed	 to	
increase the detoxification enzymes (24).
The	allium	vegetable	group	includes	onions,	leeks	and	chives.	These	vegetables	are	
the source of diallyl sulfide and allyl methyl trisulfide, which have been shown to induce 
enzymatic detoxification systems (25).
Citrus	fruits	are	rich	in	vitamin	C,	one	of	an	antioxidant	that	may	protect	cell	mem-
branes	 and	DNA	 from	oxidative	 damage.	Cumarins	 are	 the	 second	 active	 compound	
characteristic	for	citrus	fruits,	and	also	for	some	vegetables.	Study	results	showed	that	
cumarins increase the activity of glutathione transferase, one of the detoxification en-
zymes	(26).
Green	leafy	vegetables	contain	lutein	that	has	antioxidant	activity,	and	may	protect	
against damage caused by free radicals. It also contains folic acid, deficiency of which 
may	lead	to	chromosomal	damage	and	reduced	methylation	of	DNA	resulting	in	loss	of	
control	of	the	proper	expression	of	genes	(27).
Orange	vegetables	and	some	fruits	like	mango	are	the	part	of	diet	rich	in	beta	caro-
tene.	These,	like	other	carotenoids,	play	protective	role	as	antioxidants,	and	after	change	
in	metabolic	pathway	 into	 retinol	play	 a	 role	 in	differentiation	of	normal	 epithelium.	
Beta	 carotene	may	 further	 inhibit	 cell	 proliferation	 and	may	 induce	 increased	 cell	 to	
cell	communication.	This	disturbance	leads	to	loss	of	control	and	is	common	feature	of	
cancer	(28,	29).
Analysis made by Steinmetz revealed statistically significant protective effect of 
fruits	 and	 vegetables	 in	 the	 etiology	 of	 colorectal	 cancer	 in	 about	 75%	 of	 published	
case-control	studies	(30).	Cohort	studies	provided	different	results.	Giovannucci	in	1992	
found 47% statistically significant reduction in colorectal cancer polyps (17), however, 
later	analysis	of	the	same	study	group	made	by	Michaels	did	not	support	previous	results	
(31).	Some	other	cohort	studies,	like	the	Iowa	Women’s	Health	Study	(19),	the	Caerphil-
ly	Study	(32),	the	Adventist	Health	Study	(33),	the	Swedish	Mammography	Screening	
Cohort (21) also did not show statistically significant protective effect of vegetables. In 
the	Food,	Nutrition,	Physical	Activity,	and	the	Prevention	of	Cancer:	a	Global	Perspec-
tive	report	(34),	the	authors	observed	decreased	risk	with	increased	intake	of	vegetables	
in	thirteen	of	cohort	studies,	however,	only	in	two	of	them	the	results	were	statistically	
significant. 
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In	general,	the	reduction	of	cancer	risk	for	all	cancers,	due	to	high	consumption	of	
vegetables	and	fruits	is	estimated	at	50%	(35).
Further	well-organised	etiological	studies	are	needed	to	clarify	the	role	of	fruits	and	
vegetables	consumption	in	colorectal	cancer.
Howe	 investigated	 the	 role	of	vitamins	 in	metaanalysis	of	13	case-control	 studies	
and	found	15%	reduction	of	colorectal	cancer	risk	among	those,	whose	diet	was	reach	
in	vitamin	C	(15).	The	consumption	of	at	least	157	mg	of	vitamin	C	daily	decreased	by	
60%	the	colorectal	cancer	risk	in	the	study	published	by	Ferraroni	(36).	In	the	Cancer	
Prevention	Study	–	II	Jacobs	observed	decreased	risk	of	rectal	cancer	death	10-years	af-
ter	supplementation	of	vitamin	C	(37).	Although	most	studies	suggested	protective	effect	
of vitamin C, not all results were statistically significant.
Similar inconsistent findings come from the studies investigating the role of vitamin 
E.	Though	case-control	studies	showed	decreased	risk	of	colorectal	cancer	the	ATBC,	
the NHS and the HPFS did not support the protective effect (38, 39) the findings from 
of	vitamin	E.
Inconsistent	were	also	reports	on	the	role	of	carotenoids.	La	Vecchia	reported	over	
50%	reduction	of	the	colorectal	cancer	risk	in	the	group	with	the	upper	intake	of	beta-	
-carotene (40) as opposed to Enger (41) and Slattery (42) who did not confirm these 
observations.	Similarly,	intervention	trials,	such	as	the	Polyp	Prevention	Study	(43),	the	
Australian Polyp Prevention Trial (44) failed to show benefit from supplementation of 
20	to	30	mg	of	beta-carotene.	Only	in	the	Antioxidant	Polyp	Prevention	Study	among	
non-drinkers and non-smokers, supplementation of 25 mg of beta-carotene significantly 
decreased	by	44%	the	risk	of	polyps	development	in	the	bowel.
Figure 4.2. The role of eatable plants and their compounds in the etiology of colorectal cancer
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Folate
Folate	is	one	of	 the	nutritional	factors	 that	play	an	important	role	 in	 the	pathogenesis	
of	several	disorders	 in	humans	 including	cardiovascular	disease	(45),	neural	 tube	and	
some	other	congenital	defects	 (46,	47).	For	 the	 last	years,	 folate	was	also	 intensively	
investigated	as	a	potential	actor	 in	 the	etiology	of	colorectal	cancer.	Potential	mecha-
nisms of the folate deficiency in the colorectal carcinogenesis are aberrant genomic and 
site-specific DNA methylation, increased mutagenesis, hyperproliferation and abnormal 
apoptosis.	Folate	also	modulates	DNA	methylation	and	thus	determinates	gene	expres-
sion	and	maintains	integrity	and	stability	of	DNA	(48).
Epidemiologic	studies	on	the	role	of	folic	acid	in	colorectal	cancer	provided	different	
results,	however,	they	seem	to	be	more	consistent	than	evidence	on	other	micronutrients.	
Kim	assessed	the	role	of	folate	in	cancers	of	different	sites	and	found	about	35%	reduc-
tion	in	risk	among	those,	who	consumed	higher	amount	of	folic	acid	(49).	Giovannucci	
in	the	Health	Professionals	Follow-up	Study	observed	70%	risk	reduction	in	the	group	
of	high-folate	and	methionine	and	low	alcohol	intake	compared	to	low-folate	and	math-
ionine	and	high	alcohol	intake	(50).	Protective	effect	of	folate	was	also	observed	in	the	
Nurses’	Health	Study	(51)	and	the	Nutritional	Health	and	Nutrition	Examination	Survey	
I	(52).
The	effect	of	dietary	folic	acid	also	depends	on	the	individual	predisposition.	Indi-
viduals	with	MTHFR	677	TT	genotype	with	inadequate	intake	of	folate	and	relatively	
high	consumption	of	alcohol	presented	an	increased	risk	of	colorectal	cancer	(53).
To	identify	the	real	role	of	folate	in	the	etiology	of	colorectal	cancer	some	large,	ran-
domised,	double	blind,	placebo-controlled	studies	are	ongoing,	however	it	is	not	clear,	if	
the results confirm the protective effect of folic acid (54).
Meat and dietary fat
Among	others,	also	meat	and	dietary	 fat	were	considered	as	potential	 risk	 factors	 for	
colorectal	cancer.	Red	meat	is	a	source	of	saturated	fatty	acids	(SFAs).	Higher	consump-
tion	of	SFAs	increases	the	production	of	secondary	bile	acids,	which	irritate	and	dam-
age	intestinal	mucose	(55).	SFAs	increase	production	of	diacylglicerols,	which	disturb	
appropriate	proliferation	of	enterocytes.	Red	meat	is	also	a	main	source	of	cholesterol.	
The	metabolites	of	cholesterol	(coprostans,	cholestans,	etc.)	show	carcinogenic	ability.	
Moreover,	red	meat	is	usually	cooked	at	high	temperatures,	and	thus,	is	a	source	of	PAHs	
and	heterocyclic	amines,	which	are	well-known	carcinogens	(56).
Willet	in	1990	observed	increased	risk	of	colon	cancer	among	women,	who	frequently	
consumed	red	meat	(57).	Giovannucci	published	in	1994	the	results	of	the	study	showing	
the	increased	risk	of	colorectal	cancer	among	men	who	consumed	at	least	5	portions	of	
red	meat	per	week	(58).	Inversely,	the	Cancer	Prevention	Study	–	II	showed	no	differ-
ence	in	the	risk	of	colorectal	cancer	death	among	the	highest	and	the	lowest	level	of	meat	
consumption	 (59).	Lack	of	 relationship	was	also	observed	 in	 the	 Iowa	Women	Study	
(60),	in	the	study	in	Netherlands	(61),	among	Finland	men	(62),	in	Norway	(63),	among	
women	in	New	York	(64),	Lutheran	Brotherhood	(65)	and	in	the	Seven	Countries	Study	
(66).	Up	to	date	there	is	no	clear	evidence	showing	the	association	between	the	consump-
tion	of	red	meat	and	the	increasing	risk	of	colorectal	cancer.	More	evident	seems	to	be	
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relationship	between	consumption	of	very-well	cooked	meat	and	meat	cooked	in	direct	
contact with flames that rises the risk of colorectal cancer (67).
Similar	inconsistent	results	were	observed	in	the	dietary	fat	analyses.	Although	inves-
tigations	made	in	eighties	and	nineties	showed	proportional	relationship	between	SFAs	
and colorectal cancer risk (68, 69), and inverse association due to fish oil consumption 
(70), later observations did not confirm these findings. Giovannucci observed increased 
risk	only	for	 those,	who	consumed	red	meat.	Poultry	and	fat	 from	dairy	products	did	
not	 increase	 the	colorectal	cancer	 risk	 (71).	Braga	discovered	decreased	 risk	only	 for	
those,	who	consumed	at	least	43	grams	of	olive	oils.	Other	sources	of	fat	did	not	sig-
nificantly influence the risk estimates (72). Fatty acids intake did not rise the colorectal 
cancer	 risk	 in	 the	Kaiser	Permanente	Medical	Care	Program	 (73),	 in	 central	Sweden	
(74),	and	among	French-Canadians	in	Montreal	(75).	Finally,	after	analysis	of	available	
evidence	the	Panel	of	WCRF	and	AICR	stated	in	the	Food,	Nutrition,	Physical	Activity,	
and	the	Prevention	of	Cancer:	a	Global	Perspective	(2007)	“There	is	a	limited	amount	of	
fairly	consistent	evidence	suggesting	that	consumption	of	foods	containing	animal	fat	is	
a	cause	of	colorectal	cancer”	(76).	Hence,	the	role	of	red	meat	and	animal	fat	should	be	
further	investigated.
Calcium and dairy products
Calcium	intake	may	decrease	colorectal	cancer	risk.	Possible	mechanism	explaining	the	
role of calcium is that intracellular calcium directly influences cell growth and apoptosis. 
Calcium	may	also	bind	to	bile	and	fatty	acids,	preventing	them	from	damaging	the	intes-
tinal	lining	(77).	There	are	a	lot	of	epidemiologic	studies	that	investigated	the	potential	
role of calcium and dairy products. Analysis of fifteen case-control and eight cohort stud-
ies published till 1998 made by Martinez found statistically significant effect of calcium 
on colorectal cancer risk only in five of case-control and in one cohort study (78). In the 
ATBC	study	and	in	the	HPFS	study	the	risk	of	colorectal	cancer	in	the	group	of	the	high-
est	consumption	of	calcium	was	decreased	by	30	to	40%	(79,	80).	The	protective	effect	
of	calcium	was	also	noticed	by	Cho.	The	author	in	the	meta-analysis	of	10	cohort	studies	
showed significant 14% risk reduction attributed to higher calcium intake (81). The asso-
ciation was not confirmed after analysis of 27 case-controls and 16 cohort studies made 
by	Bergsma-Kadijk	(82).	Up	to	date,	the	available	evidence	is	limited.	Study	results	are	
inconsistent	and	some	of	them	did	not	take	into	account	important	potential	confounders	
like fibre, vitamins and genetic predisposition.
Intervention	data	showed	that	calcium	reduced	proliferation	in	the	upper	part	of	the	
colonic	 crypt	 (83),	 however,	 these	 observations	were	 not	 supported	 by	 other	 authors	
(84).	Calcium	may	also	have	effect	on	the	growth	of	new	adenomas	(85).	The	results	
of	randomised	controlled	trial	published	by	Baron,	showed	that	the	supplementation	of	
1200	mg	calcium	daily	decreased	the	risk	of	colorectal	adenomas	by	up	to	20%	com-
pared	 to	placebo	 (86).	 In	 their	 summary	of	 the	 available	 evidence	Potter	 and	Hunter	
reported:	 “there	 is	 evidence	 that	 both	 dairy	 foods	 and	 supplemental	 calcium	may	 be	
inversely	associated	with	(colorectal	cancer)	risk”	(87).
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Other diet-related factors
Giovannucci	analysed	the	role	of	coffee	in	the	meta-analysis	of	12	case-control	and	5	
cohort	studies	(88).	Overall,	inverse	association	was	observed,	however,	there	is	no	clear	
biological	rationale	for	the	causal	effect.	Hence	it	would	be	premature	to	conclude	that	
the	coffee	causally	diminishes	the	risk	of	the	development	of	colorectal	cancer.
The	 risk	of	 colorectal	 cancer	may	be	 increased	by	 the	 consumption	of	 the	higher	
amount	of	alcohol.	An	acetaldehyde,	a	metabolite	of	ethanol,	is	a	potent	DNA	adducts	
former	(89).	An	alcohol	may	also	inhibit	DNA	repair	by	induction	of	microsomal	cyto-
chrome	P-450	activity	that	may	result	in	enhanced	level	of	electrotrophilic	metabolites	
of procarcinogens, which are not readily detoxified. In addition, chronic consumption 
of	alcohol	has	been	found	to	depress	the	activity	of	O6-methylguanine	transferase	–	an	
enzyme	involved	in	the	repair	of	carcinogen-induced	DNA	alkylation	(90).
Twenty-four	cohort	studies	on	alcoholic	drinks	and	thirteen	cohort	and	forty-one	case-
control	studies	on	intake	of	ethanol	that	were	published	to	2008	were	analysed	by	the	
Panel	of	the	WCRF	and	the	AICR.	The	increased	risk	of	colorectal	cancer	was	observed	
in	eighteen	studies	on	alcoholic	drinks,	however,	only	in	four	of	them	the	results	were	
statistically significant. The meta-analysis of all studies evaluating the role of alcoholic 
drinks,	showed	no	increase	in	risk,	giving	the	summary	effect	of	1.01	per	drink	over	day.	
The	meta-analysis	of	pure	ethanol	intake	showed	that	the	intake	of	10	g	ethanol	per	day	
significantly increases by 9% the risk of the development of colorectal cancer (91).
Physical activity
There are a lot of studies showing benefit from physical activity in chronic diseases. 
Most	 of	 the	 published	 study	 results	 showed	 inverse	 association	 between	 the	 level	 of	
occupational	activity,	leisure	activity,	and	total	activity	(92).	Hypotheses	explaining	the	
role	of	physical	activity	pointed	at	stimulation	of	colon	peristalsis	by	decreasing	the	con-
tact	time	of	potential	carcinogens	in	digested	mass.	Physical	activity	seems	to	have	the	
positive	effect	on	the	immune	system	(93).	Furthermore,	higher	physical	activity	level	
helps	to	maintain	normal	body	weight	and	thereby	helps	to	control	appropriate	level	of	
insulin	and	other	growth	factors	(like	IGF-I)	playing	protective	role	in	carcinogenesis,	
also	in	colorectal	cancer	(94,	95).
In	the	epidemiologic	studies,	as	presented	by	the	Panel	of	WCRF	and	AICR,	total	
physical	activity	was	analysed	in	eleven	cohort	studies,	eight	of	them	showed	decreased	
risk of colorectal cancer, but only three were statistically significant. Additional 12 co-
hort	studies	considered	occupational	physical	activity.	All	of	 them	reported	decreased	
colorectal cancer risk, however, only two of them were statistically significant. Recrea-
tional	physical	activity	was	evaluated	in	24	cohort	studies	and	most	of	them	reported	de-
creased	colorectal	cancer	risk	in	the	group	of	higher	physical	activity	level	(96).	Samad	
published	in	2005	a	meta-analysis	of	available	evidence	on	physical	activity	and	the	risk	
of	colorectal	cancer.	The	author	observed	about	20%	decrease	of	the	risk	among	men	for	
occupational and leisure activity (pooled estimates: RR = 0.798; 95% CI: 0.729–0.872; 
and RR = 0.788; 95% CI: 0.680–0.912, respectively). The presented analysis failed to 
show positive effect of occupational activity among women, confirmed, however, the 
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protective role of leisure physical activity (RR = 0.714; 95% CI: 0.574–0.888). Meta-
analysis	of	case-control	 studies	made	by	 the	same	author	showed	about	30–50%	risk	
reduction	 for	 both	genders	 either	 for	 occupational	 or	 leisure	 activity	 (97).	Finally,	 to	
summarise	 the	 role	of	physical	 activity	 in	 the	etiology	of	colorectal	 cancer	 the	Panel	
of	the	WCRF	and	AICR	conclude:	“the	evidence	that	higher	levels	of	physical	activity,	
within	the	range	studied,	protects	against	colon	cancer,	is	convincing”	(96).
inflammatory Prostaglandins and aspirin
Aspirin inhibits the formation of the pro-inflammatory COX-2 enzyme. This enzyme is 
over	expressed	in	adenomas	and	some	cancers.	Inhibition	of	this	enzyme	has	led	to	the	
regression	of	tumours.	Some	studies	showed	that	people	who	take	aspirin	regularly	have	
a	reduced	risk	of	colorectal	cancer.	Most	case-control	studies	showed	the	reduction	in	
colorectal cancer risk by 30 to 70% and significant effect was observed for duration of 
aspirin	use	longer	than	3	years.	The	analysis	of	cohort	studies	showed	22%	statistically	
significant reduction in risk (98). The benefit was observed for the longer duration and 
higher	doses.	 In	 the	Nurses’	Health	Study	decreasing	 trend	 for	 colorectal	 cancer	 risk	
with	the	duration	and	higher	doses	of	aspirin	was	also	observed.	The	highest	risk	reduc-
tion (RR = 0.47) was observed for women, who used more than 14 aspirin per week 
for longer than 10 years (99). Randomized controlled trials, however, did not confirm 
previous	observations.	In	the	Physicians’	Health	Study	(aspirin	dose	325	mg/day)	and	
in	the	Women’s	Health	Study	(100	mg/day)	the	authors	did	not	observe	protective	effect	
(100,	101).	However,	among	patients	with	the	history	of	colorectal	adenomas	the	use	of	
NSAIDs significantly reduced the risk of colorectal adenoma (102). The U.S. Preventive 
Services	Task	Force	(USPSTF),	on	the	basis	of	the	available	evidence,	“has	found	good	
evidence	that	low-dose	aspirin	does	not	lead	to	a	reduction	in	the	incidence	of	colorec-
tal	cancer,	fair	evidence	that	higher-dose	aspirin	and	NSAIDs	may	be	associated	with	
a	reduction	in	the	incidence	of	colorectal	cancer,	and	fair	evidence	that	aspirin	used	over	
longer	periods	may	be	associated	with	a	reduction	 in	 the	 incidence	of	colorectal	can-
cer.”	However,	either	the	U.S.	Preventive	Services	Task	Force	or	the	American	Cancer	
Society	does	not	recommend	use	of	aspirin	or	other	NSAID	to	prevent	colorectal	cancer	
because	of	potential	side	effects,	especially	gastrointestinal	bleeding	(103).
environmental factors
Ionising	 radiation	was	also	considered	as	a	potential	 risk	 factor	 for	colorectal	cancer.	
Excess	of	risk	was	observed	among	Japanese	atomic	bomb	survivors,	but	only	for	colon	
not	for	rectal	cancer	(104).	The	follow-up	of	groups	exposed	to	medical	doses	did	not	
show	consistent	results.
Asbestos	is	another	potential	risk	factor	for	colorectal	cancer.	Morgan	published	a	re-
view	of	 the	published	papers	on	asbestos	and	the	risk	of	death	due	to	gastrointestinal	
cancer.	The	author	observed	elevated	risk	of	death	from	oesophageal	and	stomach	can-
cer,	however,	the	colorectal	cancer	risk,	although	slightly	increased,	was	not	statistically	
significant (105). Kang observed the increased risk of death among workers exposed to 
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high	level	of	asbestos,	however	the	author	also	stated	that	the	magnitude	of	the	effect	
was	very	small	(106).
other possible risk factors
Other	possible	risk	factors	contributing	to	the	development	of	colorectal	cancer	are	in-
flammatory bowel disease (107), Crohn’s disease (108), cholecystectomy (109), use of 
laxative	(110)	and	hormone	replacement	therapy.	There	is	evidence	that	estrogen	recep-
tor	hypermethylation	increases	with	age	and	that	is	central	feature	of	colon	cancer	(111).	
Hormone	 replacement	 therapy	may	 complement	 the	 declining	 endogenous	 estrogens	
level	and	 thus	 reduce	 the	probability	 that	 the	estrogen	 receptor	gene	will	be	 silenced	
by	methylation	(112).	In	human	epidemiologic	studies	some	investigators	reported	an	
approximate	halving	the	risk	of	colorectal	cancer	with	the	use	of	hormone	replacement	
therapy	(113,	114).
The	knowledge	on	colorectal	cancer	risk	factors	is	inconsistent	and	requires	further	
investigations.	There	are	probably	others	risk	factors	except	those	mentioned	above	that	
contribute	to	the	development	of	colorectal	cancer.	Nowadays,	the	large	ongoing	studies	
are	trying	to	explain	the	real	role	of	dietary	factors	in	the	etiology	of	this	disease	and	
probably more, good quality studies will be required to confirm discussed relationships.
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